What the industry experts are saying about Drug Safety for Marketed Drugs
14 April 2006, NetworkPharma Ltd, Oxford, UK have published the latest in their KeywordPharma series of brand new conference reports intended for individuals working in and around the global pharmaceutical industry.
Drug Safety for Marketed Drugs; in-depth report from the eyeforpharma conference, Amsterdam, 22-23 November 2005 is now available for purchase.
The issue editor, Martin Fagan, said: "Speakers and attendees at the eyeforpharma conference on Drug Safety for Marketed Drugs, held in Amsterdam on 22-23 November 2005, encompassed a broad mix, ranging from epidemiology, clinical development, pharmacovigilance, data management, clinical research organisations, health authority, information technology (IT) and management, including some involved in marketing. This mix reflects the interdisciplinary field of drug safety surveillance. However, the telling gap was the lack of a significant sales and marketing presence."
Peter Llewellyn, Managing Director of NetworkPharma Ltd commented, "This Conference Insights review comprises the highlights of a selection of presentations from the eyeforpharma conference, providing a platform for how and where the industry can improve drug safety. Crucially, it also outlines how companies can communicate the true and undoubted value of safety surveillance."
All KeywordPharma publications can be purchased from ThePharmYard at www.ThePharmYard.com
NOTES
About the editor
Martin Fagan is a Senior Executive Director with over 25 years experience in the healthcare, pharmaceutical, NHS (public sector) and data/IT/CRM industries, both in the UK and internationally. He has experience in start-up, rescue, organisational restructure, spin out and sales/marketing/business development in the pharmaceutical, B2B and IT industries, as well as in NHS supply. He also has extensive experience of commercial databases and patient data in clinical research, and knowledge of NPfIT and current NHS changes and opportunities through his current role as Vice President Market Insight Solutions for Infonetica.
Martin qualified as a toxicologist and, after a brief spell in research, progressed through the commercial arm in the pharmaceutical and supplies industries, including 4 years in Asia responsible for trade with over 10 countries. He established his own consulting company, Infozyme Consulting International, in 2001.
Written by pharmaceutical industry specialists, KeywordPharma publications are designed to be authoritative, relevant, succinct and helpful to pharmaceutical industry executives in their day-to-day work and in their longer term career development. Available to purchase individually as e-documents, they build into a specialist knowledge library for everyone working in and around the global pharmaceutical industry.
Developed and managed by NetworkPharma Ltd, ThePharmYard provides instant access to a unique database of specialist information which is particularly relevant to individuals working within the medical and pharmaceutical industries around the world. Titles from a diverse range of independent publishers are available to purchase in electronic document format for immediate access.
NetworkPharma Ltd is an independent, specialist company founded by Peter Llewellyn, to focus on novel approaches to disseminating information within the global medical and pharmaceutical industries. Peter Llewellyn previously founded and built the leading industry portal site, InPharm, which was subsequently purchased by John Wiley & Sons to manage alongside their other industry services, PharmaFile and Pharmafocus.
For more information contact:
For more information please contact us via our web site or directly contact Peter Llewellyn, Managing Director, NetworkPharma Ltd, email: peter@networkpharma.com, tel: +44 (0) 1865 865943
